#sglt2-inhibitors

[ follow ]
#chronic-kidney-disease-treatment #glp-1-receptor-agonists #drug-innovation #combination-therapy
Medicine
fromwww.scientificamerican.com
1 day ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
Medicine
fromNews Center
5 months ago

Diabetes Drug May Protect Against Kidney Inflammation - News Center

SGLT2 inhibition increases renal S-adenosylmethionine (SAM), causing epigenetic suppression of NF-κB–driven inflammation and protecting kidney function.
fromNews Center
8 months ago

Diabetes Drug May Serve as Alternative Treatment Option for Hydrocephalus - News Center

There is, however, no pharmacological treatment currently approved to treat hydrocephalus. Additionally, nearly 20 percent of patients with normal pressure hydrocephalus also have type 2 diabetes and take sodium/glucose cotransporter 2 (SGLT2) inhibitors to manage their blood sugar.
Alternative medicine
[ Load more ]